556 Publications COVID-19 publications - Week 17 2020 · Update April 20 - April 26, 2020, dr....

Update April 20 - April 26, 2020, dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications

categorized by relevant topics

COVID-19 publications - Week 17 2020556 Publications

PubMed based Covid-19 weekly literature updateFor those interested in receiving weekly updates

click hereFor questions and requests for topics to add send an e-mail

[email protected]

Reliable on-line resources for Covid 19

WHO Daily dashbord Country Guidance Travel restriction CDCCovid CounterAHAESCWikipediaEMEAEvidence EPPIGenomic epidemiology CEBM - OxfordNice Guidelines Covid decisions Corona Resource Center Harvard Am College of Surgeons guidelines PPE Burn Rate Calculator (CDC)Medscape Covid GuidelinesCOVID-19 resources (McMasters)

BMJCambridge Univeristy PressCochraneElsevierJAMAThe LancetNew England Journal of MedicineOxford Universtiy PressPLOSSpringer NatureWileySSRN (Preprints) COVID reference (Steinhauser Verlag)Cell Papers

http://eepurl.com/gXith5https://unwfp.maps.arcgis.com/apps/opsdashboard/index.html#/db5b5df309ac4f10bfd36145a6f8880ehttps://unwfp.maps.arcgis.com/apps/opsdashboard/index.html#/db5b5df309ac4f10bfd36145a6f8880ehttps://www.cdc.gov/coronavirus/2019-ncov/index.htmlhttps://www.worldometers.info/coronavirus/https://www.heart.org/en/about-us/coronavirus-covid-19-resourceshttps://www.escardio.org/Education/COVID-19-and-Cardiologyhttps://www.wikiwand.com/nl/COVID-19https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19https://nextstrain.org/ncovhttps://www.cebm.net/covid-19/https://www.criticalcarenice.org.uk/clinical-guidelineshttps://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center?utm_content=buffer5d9d6&utm_medium=social&utm_source=twitter&utm_campaign=bufferhttps://www.facs.org/covid-19/clinical-guidancehttps://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/burn-calculator.htmlhttps://www.medscape.com/index/list_13405_0https://www.mcmasterforum.org/find-evidence/guide-to-covid-19-evidence-sourceshttps://www.nejm.org/coronavirushttps://blogs.plos.org/plos/2020/01/novel-coronavirus-2019-ncov-outbreak/https://www.springernature.com/gp/researchers/campaigns/coronavirushttps://www.ssrn.com/index.cfm/en/coronavirus/https://covidreference.com/https://www.cell.com/2019-nCOV

COVID-19 TELEMEDIZIN (BMJ)Korean CDC Covid-19 guidelinesOxygenation Ventilation toolkit COVID-19 Projections trackerAAN - Neurology resources

GuidelinesNice Guidelines Covid decisions Korean CDC Covid-19 guidelinesIDSA COVID-19 GuidelinesAirway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020)OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020)Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients, suspected or confirmed COVID-19National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & RegistriesCAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trialLets Beat Covid-19 Survey to help plan hospital servicesCOVID IBD registry Google mobility reports per country COVID 19World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US)ICNARC report on COVID-19 in critical care - NHS April 24

Mainstream MediaRichard Lehman's COVID 19 review April 6 (BMJ)

Who will remain immune to COVID-19? (NYT)AstraZeneca’s Calquence Shows Early Promise For COVID-19 Patients (Forbes)Small Chloroquine Study Halted Over Risk of Fatal Heart Complications (NYT)

New Therapies to Treat COVID-19 (Consumer Reports)Healthcare workers 'should be screened for COVID-19 every week'

Is the Virus on My Clothes? My Shoes? My Hair? My Newspaper? (NYT)Asthma Is Absent Among Top COVID-19 Risk Factors, Early Data Shows (NYT)

Does Widespread Disinfecting Kill the Coronavirus? It’s Under Debate (NYT) Coronavirus: Which Mask Should You Wear (NYT)?

20 percent of coronavirus ICU patients in NYC need dialysis (Politico) Obesity Linked to Severe COVID-19 Disease, Especially for Younger Patients (NYT)

How good is the "6 feet" science of social distancing (NYT)How does coronavirus kill? (Science)

Basic Science

https://www.bmj.com/content/368/bmj.m1182/relatedhttps://covidtranslate.org/https://cpr.heart.org/en/resources/coronavirus-covid19-resources-for-cpr-training/oxygenation-and-ventilation-of-covid-19-patientshttp://covid%20projections%20tracherd/https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/https://www.criticalcarenice.org.uk/clinical-guidelineshttps://covidtranslate.org/https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://www.esicm.org/wp-content/uploads/2020/03/SSC-COVID19-GUIDELINES.pdfhttps://www.asahq.org/about-asa/governance-and-committees/asa-committees/committee-on-occupational-health/coronavirushttps://www.osha.gov/Publications/OSHA3990.pdfhttps://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-ventilators-and-accessories-and-other-respiratory-devices-during-coronavirushttps://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancerhttps://epidemio.wiv-isp.be/ID/Documents/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdfhttps://t.co/HtbvKckQUw?amp=1http://www.onlinejacc.org/content/early/2020/04/06/j.jacc.2020.04.002https://capacity-covid.eu/https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatmentshttps://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-indshttps://letsbeatcovid.net/https://covidibd.org/https://www.google.com/covid19/mobility/https://www.gov.uk/government/news/worlds-largest-trial-of-potential-coronavirus-treatments-rolled-out-across-the-ukhttps://www.gov.uk/government/news/worlds-largest-trial-of-potential-coronavirus-treatments-rolled-out-across-the-ukhttps://www.obgproject.com/2020/03/26/u-s-covid-19-pregnancy-registry-now-open/https://www.icnarc.org/Our-Audit/Audits/Cmp/Reportshttps://blogs.bmj.com/bmj/2020/04/06/richard-lehmans-covid-19-reviews-6-april-2020/https://www.forbes.com/sites/nathanvardi/2020/04/13/exclusive-astrazenecas-calquence-shows-early-promise-for-covid-19-patients/#49b63d6e4677https://www.nytimes.com/2020/04/12/health/chloroquine-coronavirus-trump.html?algo=identity&fellback=false&imp_id=211761614&imp_id=494670681&action=click&module=Science%20%20Technology&pgtype=Homepagehttps://www.consumerreports.org/medical-treatments-procedures/new-therapies-to-treat-covid-19/?linkId=86705821https://www.theguardian.com/world/2020/apr/16/healthcare-workers-screened-covid-19-every-week-infectious-unethicalhttps://www.nytimes.com/2020/04/17/well/live/coronavirus-contagion-spead-clothes-shoes-hair-newspaper-packages-mail-infectious.html?utm_source=pocket&utm_medium=email&utm_campaign=pockethitshttps://www.nytimes.com/2020/04/16/health/coronavirus-asthma-risk.html?smtyp=cur&smid=tw-nythealthhttps://www.nytimes.com/2020/04/14/health/disinfectant-coronavirus.html?smid=tw-nythealth&smtyp=curhttps://www.nytimes.com/interactive/2020/health/coronavirus-best-face-masks.htmlhttps://www.politico.com/news/2020/04/15/dialysis-kidney-coronavirus-188840https://www.nytimes.com/2020/04/16/health/coronavirus-obesity-higher-risk.htmlhttps://www.nytimes.com/interactive/2020/04/14/science/coronavirus-transmission-cough-6-feet-ar-ul.htmlhttps://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes#

1. Shi Y, Zhang X, Mu K et al. D3Targets-2019-nCoV: a webserver for predicting drug targets and formulti-target and multi-site based virtual screening against COVID-19. Acta Pharm Sin B 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318328

2. Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin system at the heart of COVID-19pandemic. Biochimie 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305506

3. Kim D, Lee JY, Yang JS et al. The Architecture of SARS-CoV-2 Transcriptome. Cell 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330414

4. Monteil V, Kwon H, Prado P et al. Inhibition of SARS-CoV-2 Infections in Engineered Human TissuesUsing Clinical-Grade Soluble Human ACE2. Cell 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333836

5. Macchiagodena M, Pagliai M, Procacci P. Identification of Potential Binders of the Main Protease3CL(pro) of the COVID-19 via Structure-Based Ligand Design and Molecular Modeling. Chem. Phys.Lett. 2020:137489. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313296

6. Ekins S, Mottin M, Ramos P et al. Deja vu: stimulating open drug discovery for SARS-CoV-2. DrugDiscov Today 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320852

7. Jogalekar MP, Veerabathini A, Gangadaran P. Novel 2019 coronavirus: Genome structure, clinicaltrials, and outstanding questions. Exp. Biol. Med. (Maywood) 2020:1535370220920540.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306751

8. Jackson DJ, Busse WW, Bacharier LB et al. Association of Respiratory Allergy, Asthma andExpression of the SARS-CoV-2 Receptor, ACE2. J Allergy Clin Immunol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333915

9. Joshi RS, Jagdale SS, Bansode SB et al. Discovery of Potential Multi-Target-Directed Ligands byTargeting Host-specific SARS-CoV-2 Structurally Conserved Main Protease($). J Biomol Struct Dyn2020:1-16. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329408

10. Jaimes JA, Andre NM, Chappie JS et al. Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop. J.Mol. Biol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320687

11. Pachetti M, Marini B, Benedetti F et al. Emerging SARS-CoV-2 mutation hot spots include a novelRNA-dependent-RNA polymerase variant. J Transl Med 2020; 18:179.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321524

12. Sportelli MC, Izzi M, Kukushkina EA et al. Can Nanotechnology and Materials Science Help the Fightagainst SARS-CoV-2? Nanomaterials (Basel) 2020; 10. http://www.ncbi.nlm.nih.gov/pubmed/?term=32326343

Biomarkers - Genetics1. Zhang L, Pang R, Xue X et al. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six

donors who have recovered from COVID-19. Aging (Albany NY) 2020; 12.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320384

2. Ganji A, Farahani I, Khansarinejad B et al. Increased expression of CD8 marker on T-cells in COVID-19patients. Blood Cells Mol. Dis. 2020; 83:102437. http://www.ncbi.nlm.nih.gov/pubmed/?term=32325421

3. Xiang F, Wang X, He X et al. Antibody Detection and Dynamic Characteristics in Patients with COVID-19. Clin Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306047

4. Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19patients. Clin Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306036

5. Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation andCryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020; 8.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326509

6. Baek YH, Um J, Antigua KJC et al. Development of a reverse transcription-loop-mediated isothermalamplification as a rapid early-detection method for novel SARS-CoV-2. Emerg Microbes Infect 2020:1-31. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306853

7. Yongchen Z, Shen H, Wang X et al. Different longitudinal patterns of nucleic acid and serology testingresults based on disease severity of COVID-19 patients. Emerg Microbes Infect 2020:1-14.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306864

8. Wang H, Li X, Li T et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J ClinMicrobiol Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333222

9. De Virgilio A, Pellini R, Mercante G et al. Who should perform the rhinopharyngeal swab in COVID-19positive patients? Head Neck 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329138

10. Wang X, Tan L, Wang X et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315809

11. Lu R, Wu X, Wan Z et al. A Novel Reverse Transcription Loop-Mediated Isothermal AmplificationMethod for Rapid Detection of SARS-CoV-2. Int J Mol Sci 2020; 21.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325642

12. Tersalvi G, Vicenzi M, Calabretta D et al. Elevated troponin in patients with Coronavirus Disease 2019(COVID-19): possible mechanisms. J. Card. Fail. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315733

13. Paoli D, Pallotti F, Colangelo S et al. Study of SARS-CoV-2 in semen and urine samples of a volunteerwith positive naso-pharyngeal swab. J. Endocrinol. Invest. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329026

14. Li Y, Hu Y, Yu Y et al. Positive result of Sars-Cov-2 in faeces and sputum from discharged patientwith COVID-19 in Yiwu, China. J Med Virol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311109

15. Yong G, Yi Y, Tuantuan L et al. Evaluation of the auxiliary diagnostic value of antibody assays for thedetection of novel coronavirus (SARS-CoV-2). J Med Virol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320064

16. Sullivan PS, Sailey C, Guest JL et al. Detection of SARS-CoV-2 RNA and Antibodies in DiverseSamples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva,and Oropharyngeal Samples. JMIR Public Health Surveill 2020; 6:e19054.http://www.ncbi.nlm.nih.gov/pubmed/?term=32310815

17. Lorusso A, Calistri P, Mercante MT et al. A "One-Health" approach for diagnosis and molecularcharacterization of SARS-CoV-2 in Italy. One Health 2020:100135. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313828

18. Fan Q, Pan Y, Wu Q et al. Anal swab findings in an infant with COVID-19. Pediatr Investig 2020; 4:48-50. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328338

19. Huang X, Wei F, Yang Z et al. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study. Prehosp. Disaster Med. 2020:1-9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326988

20. Dohla M, Boesecke C, Schulte B et al. Rapid point-of-care testing for SARS-CoV-2 in a communityscreening setting shows low sensitivity. Public Health 2020; 182:170-172.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334183

21. Lippi G, Henry BM. Eosinophil count in severe coronavirus disease 2019 (COVID-19). QJM 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315429

22. Qian GQ, Zhang X, Ma AHY, Yang NB. Response letter to Eosinophil count in severe coronavirusdisease 2019 (COVID-19). QJM 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315421

23. Bauer DC, Tay AP, Wilson LOW et al. Supporting pandemic response using genomics andbioinformatics: a case study on the emergent SARS-CoV-2 outbreak. Transbound Emerg Dis 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306500

24. Epstein J, Burnouf T. Points to consider in the preparation and transfusion of COVID-19 convalescentplasma. Vox Sang 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319102

Children1. Shi Y, Wang X, Liu G et al. A quickly, effectively screening process of novel corona virus disease

2019 (COVID-19) in children in Shanghai, China. Ann Transl Med 2020; 8:241.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309388

2. Zhang J, Shuai L, Yu H et al. Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak. Asian JPsychiatr 2020; 51:102077. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315967

3. Leboulanger N, Sagardoy T, Akkari M et al. COVID-19 and ENT Pediatric otolaryngology during theCOVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP)and French Society of Otorhinolaryngology (SFORL). Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312676

4. Hrusak O, Kalina T, Wolf J et al. Flash survey on severe acute respiratory syndrome coronavirus-2infections in paediatric patients on anticancer treatment. Eur. J. Cancer 2020; 132:11-16.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305831

5. Chiotos K, Hayes M, Kimberlin DW et al. Multicenter initial guidance on use of antivirals for childrenwith COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32318706

6. Kan MJ, Grant LMC, Muna MA, Greenhow TL. Fever without a source in a young infant due to SARS-CoV-2. J Pediatric Infect Dis Soc 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32318729

7. Ogimi C, Kim YJ, Martin ET et al. What's New With the Old Coronaviruses? J Pediatric Infect Dis Soc2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314790

8. Castagnoli R, Votto M, Licari A et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320004

9. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue? Pediatr. Dermatol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315079

10. Shen Q, Wang M, Che R et al. Consensus recommendations for the care of children receivingchronic dialysis in association with the COVID-19 epidemic. Pediatr. Nephrol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333285

11. Licciardi F, Giani T, Baldini L et al. COVID-19 and what pediatric rheumatologists should know: areview from a highly affected country. Pediatr. Rheumatol. Online J. 2020; 18:35.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321540

12. Shen KL, Yang YH, Jiang RM et al. Updated diagnosis, treatment and prevention of COVID-19 inchildren: experts' consensus statement (condensed version of the second edition). World J Pediatr2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333248

13. Levy E, Blumenthal J, Chiotos K, Dearani JA. COVID-19 FAQ's in Pediatric Cardiac Surgery. World JPediatr Congenit Heart Surg 2020:2150135120924653. http://www.ncbi.nlm.nih.gov/pubmed/?term=32316830

Clinical Features1. Gianotti R, Veraldi S, Recalcati S et al. Cutaneous Clinico-Pathological Findings in three COVID-19-

Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Derm. Venereol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315073

2. Singhania N, Bansal S, Singhania G. An Atypical Presentation of Novel Coronavirus Disease 2019(COVID-19). Am. J. Med. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320693

3. Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am. J.Otolaryngol. 2020:102483. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307189

4. Salducci M, La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin.Ter. 2020; 171:e189-e191. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323704

5. Hassan SA, Sheikh FN, Jamal S et al. Coronavirus (COVID-19): A Review of Clinical Features,Diagnosis, and Treatment. Cureus 2020; 12:e7355. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328367

6. Rodriguez-Morales AJ, Rodriguez-Morales AG, Mendez CA, Hernandez-Botero S. Tracing New ClinicalManifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-

2 Divergence. Curr Trop Med Rep 2020:1-4. http://www.ncbi.nlm.nih.gov/pubmed/?term=323138047. Wee LE, Chan YFZ, Teo NWY et al. The role of self-reported olfactory and gustatory dysfunction as a

screening criterion for suspected COVID-19. Eur Arch Otorhinolaryngol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32328771

8. Poggiali E, Ramos PM, Bastoni D et al. Abdominal Pain: A Real Challenge in Novel COVID-19Infection. Eur J Case Rep Intern Med 2020; 7:001632. http://www.ncbi.nlm.nih.gov/pubmed/?term=32309266

9. Marzano AV, Genovese G, Fabbrocini G et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305439

10. Shah M, Sachdeva M, Dodiuk-Gad RP. COVID-19 and Racial Disparities. J Am Acad Dermatol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305444

11. Amatore F, Macagno N, Mailhe M et al. SARS-CoV-2 infection presenting as a febrile rash. J Eur AcadDermatol Venereol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330336

12. Avellana Moreno R, Villa E, Avellana Moreno V et al. Cutaneous manifestation of COVID-19 in images:A case report. J Eur Acad Dermatol Venereol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330339

13. Hedou M, Carsuzaa F, Chary E et al. Comment on "Cutaneous manifestations in COVID-19: a firstperspective " by Recalcati S. J Eur Acad Dermatol Venereol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314436

14. Piccolo V, Neri I, Filippeschi C et al. Chilblain-like lesions during COVID-19 epidemic: a preliminarystudy on 63 patients. J Eur Acad Dermatol Venereol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330334

15. Recalcati S, Barbagallo T, Frasin LA et al. Acral cutaneous lesions in the Time of COVID-19. J Eur AcadDermatol Venereol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330324

16. Tammaro A, Adebanjo GAR, Parisella FR et al. Cutaneous manifestations in COVID-19: theexperiences of Barcelona and Rome. J Eur Acad Dermatol Venereol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330340

17. van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the firstmanifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329915

18. Loffredo L, Pacella F, Pacella E et al. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330304

19. Xie J, Ding C, Li J et al. Characteristics of Patients with Coronavirus Disease (COVID-19) Confirmedusing an IgM-IgG Antibody Test. J Med Virol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330303

20. Lovell N, Maddocks M, Etkind SN et al. Characteristics, symptom management and outcomes of 101patients with COVID-19 referred for hospital palliative care. J Pain Symptom Manage 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325167

21. Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, andOutcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320003

22. Hufert F, Spiegel M. Coronavirus: from common cold to severe pulmonary failure: Chronology of apandemia. Monatsschr. Kinderheilkd. 2020.

23. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue? Pediatr. Dermatol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315079

CNS1. Das G, Mukherjee N, Ghosh S. Neurological Insights of COVID-19 Pandemic. ACS Chem Neurosci

2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=323202112. Brown EE, Kumar S, Rajji TK et al. Anticipating and Mitigating the Impact of the COVID-19 Pandemic

on Alzheimer's Disease and Related Dementias. Am J Geriatr Psychiatry 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331845

3. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease(COVID-19): Encephalopathy. Cureus 2020; 12:e7352. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328364

4. Villalba NL, Maouche Y, Ortiz MBA et al. Anosmia and Dysgeusia in the Absence of Other RespiratoryDiseases: Should COVID-19 Infection Be Considered? Eur J Case Rep Intern Med 2020; 7:001641.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309267

5. Natoli S, Oliveira V, Calabresi P et al. Does SARS-Cov-2 invade the brain? Translational lessons fromanimal models. Eur. J. Neurol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333487

6. Sellner J, Taba P, Ozturk S, Helbok R. The need for neurologists in the care of COVID-19 patients. Eur.J. Neurol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323891

7. Virani A, Rabold E, Hanson T et al. Guillain-Barre Syndrome associated with SARS-CoV-2 infection.IDCases 2020:e00771. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313807

8. Yan CH, Faraji F, Prajapati DP et al. Self-reported olfactory loss associates with outpatient clinicalcourse in Covid-19. Int Forum Allergy Rhinol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329222

9. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J.Clin. Neurosci. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312628

10. Finsterer J, Stollberger C. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients. J MedVirol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311107

11. Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARS-CoV-2) diseaseand their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320066

12. Spinato G, Fabbris C, Polesel J et al. Alterations in Smell or Taste in Mildly Symptomatic OutpatientsWith SARS-CoV-2 Infection. JAMA 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320008

13. Klopfenstein T, Kadiane-Oussou NJ, Toko L et al. Features of anosmia in COVID-19. Med Mal Infect2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305563

14. Tipton PW, Wszolek ZK. What can Parkinson's disease teach us about COVID-19? Neurol. Neurochir.Pol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323862

15. Vinayachandran D, Balasubramanian S. Is Gustatory Impairment the First Report of an OralManifestation in COVID-19? Oral Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=3233348

Complications1. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental

pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312574

2. Santoso A, Pranata R, Wibowo A et al. Cardiac injury is associated with mortality and critically illpneumonia in COVID-19: A meta-analysis. Am J Emerg Med 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331955

3. Zochios V, Brodie D, Charlesworth M, Parhar KK. Delivering extracorporeal membrane oxygenation forpatients with COVID-19: what, who, when and how? Anaesthesia 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319081

4. Notz Q, Herrmann J, Stumpner J et al. [Anesthesia and intensive care ventilators: differences andusability in COVID-19 patients]. Anaesthesist 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333024

5. Bassi M, Anile M, Pecoraro Y et al. BEDSIDE TRANSCERVICAL-TRANSTRACHEAL POST-INTUBATION INJURY REPAIR IN A COVID-19 PATIENT. Ann Thorac Surg 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333850

6. Fogarty H, Townsend L, Ni Cheallaigh C et al. COVID-19 Coagulopathy in Caucasian patients. Br. J.Haematol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330308

7. Poissy J, Goutay J, Caplan M et al. Pulmonary Embolism in COVID-19 Patients: Awareness of anIncreased Prevalence. Circulation 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330083

8. Zhou Y, Han T, Chen J et al. Clinical and Autoimmune Characteristics of Severe and Critical Caseswith COVID-19. Clin Transl Sci 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315487

9. Li J, Wang X, Chen J et al. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes.Metab. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314455

10. Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents 2020:105982. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305588

11. Sultan I, Habertheuer A, Usman AA et al. The role of extracorporeal life support for patients withCOVID-19: Preliminary results from a statewide experience. J. Card. Surg. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333431

12. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19,SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020; 127:104362.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305883

13. Piva S, Filippini M, Turla F et al. Clinical presentation and initial management critically ill patients withsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J CritCare 2020; 58:29-33. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330817

14. Llitjos JF, Leclerc M, Chochois C et al. High incidence of venous thromboembolic events inanticoagulated severe COVID-19 patients. J Thromb Haemost 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320517

15. Foch E, Allou N, Vitry T et al. Pulmonary embolism in returning traveler with COVID-19 pneumonia. JTravel Med 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330267

16. Marone EM, Rinaldi LF. Upsurge of deep venous thrombosis in patients affected by COVID-19:preliminary data and possible explanations. J Vasc Surg Venous Lymphat Disord 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305586

17. Ullah W, Saeed R, Sarwar U et al. COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313884

18. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative orcoincidental? New Microbes New Infect 2020; 35:100669. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322398

19. Berhes M, Fabian A, Laszlo I et al. [Advanced organ support and life-sustaining therapies in criticallyill COVID-19 infected patients]. Orv. Hetil. 2020; 161:704-709. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324366

20. Laszlo I, Molnar C, Koszta G et al. [Special aspects of in-hospital resuscitation of COVID-19 patients].Orv. Hetil. 2020; 161:710-712. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324367

21. Vegh T, Laszlo I, Juhasz M et al. [Practical aspects of care for a critically ill COVID-19 infected patientin need of respiratory support]. Orv. Hetil. 2020; 161:678-684. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324362

22. Song J, Kang S, Choi SW et al. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in apatient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.Rheumatol. Int. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314010

Cured – recovered1. Chintalapudi N, Battineni G, Amenta F. COVID-19 virus outbreak forecasting of registered and

recovered cases after sixty day lockdown in Italy: A data driven model approach. J Microbiol ImmunolInfect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305271

Cardiovascular disease

1. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J EmergMed 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317203

2. Santoso A, Pranata R, Wibowo A et al. Cardiac injury is associated with mortality and critically illpneumonia in COVID-19: A meta-analysis. Am J Emerg Med 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331955

3. Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin system at the heart of COVID-19pandemic. Biochimie 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305506

4. Mahmud E, Dauerman HL, Welt FG et al. Management of Acute Myocardial Infarction During theCOVID-19 Pandemic. Catheter. Cardiovasc. Interv. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311816

5. DeFilippis EM, Farr MA, Givertz MM. Challenges in Heart Transplantation in the Era of COVID-19.Circulation 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314596

6. Duffy EY, Cainzos-Achirica M, Michos ED. Primary and Secondary Prevention of CardiovascularDisease in the Era of the Coronavirus Pandemic. Circulation 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32310675

7. Zhu H, Rhee JW, Cheng P et al. Cardiovascular Complications in Patients with COVID-19:Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep 2020; 22:32.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318865

8. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increaseddisease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis ofpublished literature. Int. J. Stroke 2020:1747493020921664. http://www.ncbi.nlm.nih.gov/pubmed/?term=32310015

9. Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-Cov2 Interaction withRenin Angiotensin System. J Am Coll Cardiol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305401

10. Mahmud E, Dauerman HL, Welt FG et al. Management of Acute Myocardial Infarction During theCOVID-19 Pandemic. J Am Coll Cardiol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330544

11. Tersalvi G, Vicenzi M, Calabretta D et al. Elevated troponin in patients with Coronavirus Disease 2019(COVID-19): possible mechanisms. J. Card. Fail. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315733

12. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Riskfactors, predictors, and complications: A review. J. Card. Surg. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306491

13. Wang NC, Jain SK, Estes NAM, 3rd et al. Priority plan for invasive cardiac electrophysiologyprocedures during the coronavirus disease 2019 (COVID-19) pandemic. J Cardiovasc Electrophysiol2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323382

14. Dabbagh MF, Aurora L, D'Souza P et al. Cardiac Tamponade Secondary to COVID-19. JACC Case Rep2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328588

15. Rodriguez-Leor O, Cid-Alvarez B. STEMI care during COVID-19: losing sight of the forest for the trees.JACC Case Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328589

16. Sorgente A, Capulzini L, Brugada P. The Known into the Unknown: Brugada syndrome and COVID-19.JACC Case Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32310242

17. Song JC, Wang G, Zhang W et al. Chinese expert consensus on diagnosis and treatment ofcoagulation dysfunction in COVID-19. Mil Med Res 2020; 7:19. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307014

18. Li JW, Han TW, Woodward M et al. The impact of 2019 novel coronavirus on heart injury: A systemicreview and Meta-analysis. Prog Cardiovasc Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305557

19. Couper K, Taylor-Phillips S, Grove A et al. COVID-19 in cardiac arrest and infection risk to rescuers: asystematic review. Resuscitation 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32325096

Diagnosis1. Borghetti A, Ciccullo A, Visconti E et al. COVID-19 diagnosis does not rule out other concomitant

diseases. Eur. J. Clin. Invest. 2020:e13241. http://www.ncbi.nlm.nih.gov/pubmed/?term=323077172. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-

19: A systematic review and meta-analysis. J Formos Med Assoc 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307322

DM -MS-Obesity1. Hanif S, Ali SN, Hassanein M et al. Managing People with Diabetes Fasting for Ramadan During the

COVID-19 Pandemic: A South Asian Health Foundation Update. Diabet. Med. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333691

2. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. DiabetesMetab Syndr 2020; 14:351-354. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311652

3. Cure E, Cumhur Cure M. Angiotensin-converting enzyme inhibitors and angiotensin receptorblockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes Metab Syndr2020; 14:349-350. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311651

4. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity ofdisease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.Diabetes Metab Syndr 2020; 14:395-403. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334395

5. Ceriello A, Stoian AP, Rizzo M. COVID-19 and diabetes management: What should be considered?Diabetes Res Clin Pract 2020:108151. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305399

6. Kasuki L, Gadelha MR. Letter to the Editor: "Our Response to COVID-19 as Endocrinologists andDiabetologists". J. Clin. Endocrinol. Metab. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315031

7. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk ofICU admission and poor short-term outcome. J Clin Virol 2020; 127:104354.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305882

8. Angelidi AM, Belanger MJ, Mantzoros CS. COVID-19 and diabetes mellitus: what we know, how ourpatients should be treated now, and what should happen next. Metabolism 2020:154245.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320742

Elderly1. Tay HS, Harwood R. Atypical presentation of COVID-19 in a frail older person. Age Ageing 2020.

http://www.ncbi.nlm.nih.gov/pubmed/?term=323153862. Etard JF, Vanhems P, Atlani-Duault L, Ecochard R. Potential lethal outbreak of coronavirus disease

(COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020.Euro Surveill 2020; 25. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317051

3. Cudjoe E, Abdullah A. Drawing on Kinship Care Support for Older People during a Pandemic (COVID-19): Practice Considerations for Social Workers in Ghana. J Gerontol Soc Work 2020:1-3.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326853

Epidemiology1. Tang L, Ye Z, Huang Z et al. Coronavirus disease 2019 (COVID-19): two case reports from a family

cluster. Ann Palliat Med 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=323120642. Shi Y, Wang X, Liu G et al. A quickly, effectively screening process of novel corona virus disease

2019 (COVID-19) in children in Shanghai, China. Ann Transl Med 2020; 8:241.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309388

3. Sokouti M, Sadeghi R, Pashazadeh S et al. Comparative Global Epidemiological Investigation ofSARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, andRecovery Rates. Arch Med Res 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32331787

4. Zhang J, Wu S, Xu L. Asymptomatic carriers of COVID-19 as a concern for disease prevention andcontrol: more testing, more follow-up. Biosci Trends 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32321904

5. Bekiros S, Kouloumpou D. SBDiEM: A new Mathematical model of Infectious Disease Dynamics.Chaos Solitons Fractals 2020:109828. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327901

6. Fanelli D, Piazza F. Analysis and forecast of COVID-19 spreading in China, Italy and France. ChaosSolitons Fractals 2020; 134:109761. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308258

7. Zhang X, Ma R, Wang L. Predicting turning point, duration and attack rate of COVID-19 outbreaks inmajor Western countries. Chaos Solitons Fractals 2020:109829. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313405

8. Khachfe HH, Chahrour M, Sammouri J et al. An Epidemiological Study on COVID-19: A RapidlySpreading Disease. Cureus 2020; 12:e7313. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313754

9. Gemelli NA. MANAGEMENT OF COVID-19 OUTBREAK IN ARGENTINA: THE BEGINNING. DisasterMed Public Health Prep 2020:1-6. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317041

10. Tiwari S, Kumar S, Guleria K. Outbreak trends of CoronaVirus (COVID-19) in India: A Prediction.Disaster Med Public Health Prep 2020:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317044

11. Liu Y, Gu Z, Xia S et al. What are the Underlying Transmission Patterns of COVID-19 Outbreak? - AnAge-specific Social Contact Characterization. EClinicalMedicine 2020:100354.http://www.ncbi.nlm.nih.gov/pubmed/?term=32313879

12. Muniz-Rodriguez K, Chowell G, Cheung CH et al. Doubling Time of the COVID-19 Epidemic byProvince, China. Emerg Infect Dis 2020; 26. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330410

13. Muniz-Rodriguez K, Fung IC, Ferdosi SR et al. Severe Acute Respiratory Syndrome Coronavirus 2Transmission Potential, Iran, 2020. Emerg Infect Dis 2020; 26. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320641

14. Park SY, Kim YM, Yi S et al. Coronavirus Disease Outbreak in Call Center, South Korea. Emerg InfectDis 2020; 26. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324530

15. Tobias A, Molina T. Is temperature reducing the transmission of COVID-19 ? Environ. Res. 2020;186:109553. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330766

16. Drame M, Godaert L, Callixte KT et al. Coping with the COVID-19 crisis in Sub-Saharan Africa: let usnot leave older people behind! Eur. Geriatr. Med. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323250

17. Sebastiani G, Massa M, Riboli E. Covid-19 epidemic in Italy: evolution, projections and impact ofgovernment measures. Eur. J. Epidemiol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306149

18. Chattu VK, Adisesh A, Yaya S. Canada's role in strengthening global health security during theCOVID-19 pandemic. Glob Health Res Policy 2020; 5:16. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328533

19. Kumar M, Kuroda K, Dhangar K. The most eagerly awaited summer of the Anthropocene: Aperspective of SARS-CoV-2 decay and seasonal change. Groundw Sustain Dev 2020:100400.http://www.ncbi.nlm.nih.gov/pubmed/?term=32322654

20. Stubinger J, Schneider L. Epidemiology of Coronavirus COVID-19: Forecasting the Future Incidencein Different Countries. Healthcare (Basel) 2020; 8. http://www.ncbi.nlm.nih.gov/pubmed/?term=32326512

21. Gupta N, Praharaj I, Bhatnagar T et al. Severe acute respiratory illness surveillance for coronavirusdisease 2019, India, 2020. Indian J Med Res 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317406

22. Khanna RC, Cicinelli MV, Gilbert SS et al. COVID-19 pandemic: Lessons learned and future directions.Indian J Ophthalmol 2020; 68:703-710. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317432

23. Yeo YY, Ganem B. The Importance of Initial Response During Outbreaks: A Perspective fromObservations on COVID-19. Infect Control Hosp Epidemiol 2020:1-6.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307029

24. Yang C, Qiu X, Fan H et al. Coronavirus disease 2019: reassembly attack of coronavirus. Int. J.Environ. Health Res. 2020:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32316751

25. Qeadan F, Honda T, Gren LH et al. Naive Forecast for COVID-19 in Utah Based on the South Koreaand Italy Models-the Fluctuation between Two Extremes. Int J Environ Res Public Health 2020; 17.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316165

26. Du W, Han S, Li Q, Zhang Z. Epidemic update of COVID-19 in Hubei Province compared with otherregions in China. Int J Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32325276

27. He D, Zhao S, Lin Q et al. The relative transmissibility of asymptomatic cases among close contacts.Int J Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315808

28. Hu Z, Cui Q, Han J et al. Evaluation and prediction of the COVID-19 variations at different inputpopulation and quarantine strategies, a case study in Guangdong province, China. Int J Infect Dis2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334117

29. Napoli PE, Nioi M. Global Spread of Coronavirus Disease 2019 and Malaria: An EpidemiologicalParadox in the Early Stage of A Pandemic. J Clin Med 2020; 9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32316118

30. McDermott CV, Alicic RZ, Harden N et al. Put a lid on it: Are faecal bio-aerosols a route oftransmission for SARS-CoV-2? J Hosp Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315667

31. Kenyon C. Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecologicalanalysis of 65 countries. J Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305488

32. Tu H, Tu S, Gao S et al. The epidemiological and clinical features of COVID-19 and lessons from thisglobal infectious public health event. J Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315723

33. La Maestra S, Abbondandolo A, De Flora S. Epidemiological trends of COVID-19 epidemic in Italyduring March 2020. From 1,000 to 100,000 cases. J Med Virol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314804

34. Aluga MA. Coronavirus Disease 2019 (COVID-19) in Kenya: Preparedness, response andtransmissibility. J Microbiol Immunol Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32331980

35. Chen FM, Feng MC, Chen TC et al. Big data integration and analytics to prevent a potential hospitaloutbreak of COVID-19 in Taiwan. J Microbiol Immunol Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327328

36. Chung YT, Yeh CY, Shu YC et al. Continuous temperature monitoring by a wearable device for earlydetection of febrile events in the SARS-CoV-2 outbreak in Taiwan, 2020. J Microbiol Immunol Infect2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32331981

37. Huang HT, Chen TC, Liu TY et al. How to prevent outbreak of a hospital-affiliated dementia day-carefacility in the pandemic COVID-19 infection in Taiwan. J Microbiol Immunol Infect 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305270

38. Makurumidze R. Coronavirus-19 disease (COVID-19): A case series of early suspected casesreported and the implications towards the response to the pandemic in Zimbabwe. J MicrobiolImmunol Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305269

39. Miglietta A, Levi M. Documented early circulation of Coronavirus Disease 2019 (COVID-19) in Florida,USA, since February 2020. J Public Health (Oxf) 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307519

40. Laurencin CT, McClinton A. The COVID-19 Pandemic: a Call to Action to Identify and Address Racialand Ethnic Disparities. J Racial Ethn Health Disparities 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306369

41. Pineda VS, Corburn J. Disability, Urban Health Equity, and the Coronavirus Pandemic: PromotingCities for All. J. Urban Health 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328866

42. Abdullah JM, Wan Ismail WFN, Mohamad I et al. A Critical Appraisal of COVID-19 in Malaysia andBeyond. Malays. J. Med. Sci. 2020; 27:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308536

43. Abduljalil JM, Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect 2020; 35:100672. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322400

44. Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology,pathogenesis and potential therapeutics). New Microbes New Infect 2020; 35:100679.http://www.ncbi.nlm.nih.gov/pubmed/?term=32322401

45. Waris A, Atta UK, Ali M et al. COVID-19 outbreak: current scenario of Pakistan. New Microbes NewInfect 2020; 35:100681. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322403

46. Columbus C, Brust KB, Arroliga AC. 2019 novel coronavirus: an emerging global threat. Proc. (Bayl.Univ. Med. Cent.) 2020; 33:209-212. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313463

47. Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L et al. Does the pathogenesis of SAR-CoV-2virus decrease at high-altitude? Respir. Physiol. Neurobiol. 2020:103443.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333993

48. Saez M, Tobias A, Varga D, Barcelo MA. Effectiveness of the measures to flatten the epidemic curveof COVID-19. The case of Spain. Sci Total Environ 2020; 727:138761.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330703

49. Tomar A, Gupta N. Prediction for the spread of COVID-19 in India and effectiveness of preventivemeasures. Sci Total Environ 2020; 728:138762. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334157

50. Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J.Exp. Med. 2020; 250:271-278. http://www.ncbi.nlm.nih.gov/pubmed/?term=32321874

51. Torres-Roman JS, Kobiak IC, Valcarcel B et al. The reproductive number R0 of COVID-19 in Peru: Anopportunity for effective changes. Travel Med Infect Dis 2020:101689.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325120

52. Yezli S, Khan A. COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in theface of political, economic, social and religious challenges. Travel Med Infect Dis 2020:101692.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330561

53. Edrada EM, Lopez EB, Villarama JB et al. First COVID-19 infections in the Philippines: a case report.Trop Med Health 2020; 48:21. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308532

54. Chowdhury A, Jahan N, Wang S. One month of the novel coronavirus 2019 outbreak: Is it still athreat? Virusdisease 2020:1-5. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313823

55. Yang WZ. [Thoughts of the COVID-19 outbreak phases changed from emergency response tocombination of emergency response and regular prevention and control]. Zhonghua Liu Xing BingXue Za Zhi 2020; 41:E045. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312021

Gastro-enterology-hepatology1. Sethi A, Swaminath A, Latorre M et al. Donning a new approach to the practice of gastroenterology:

perspectives from the COVID-19 pandemic epicenter. Clin Gastroenterol Hepatol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330565

2. Wei XS, Wang X, Niu YR et al. Diarrhea is associated with prolonged symptoms and viral carriage inCOVID-19. Clin Gastroenterol Hepatol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311512

3. Poggiali E, Ramos PM, Bastoni D et al. Abdominal Pain: A Real Challenge in Novel COVID-19Infection. Eur J Case Rep Intern Med 2020; 7:001632. http://www.ncbi.nlm.nih.gov/pubmed/?term=32309266

4. D'Amico F, Peyrin-Biroulet L, Danese S. Inflammatory bowel diseases and COVID-19: the invisibleenemy. Gastroenterology 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305331

5. Rodriguez-Lago I, Ramirez de la Piscina P, Elorza A et al. Characteristics and prognosis of patientswith inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).Gastroenterology 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330477

6. An P, Huang X, Wan X et al. ERCP during the pandemic of COVID-19 in Wuhan, China. GastrointestEndosc 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305345

7. Occhipinti V, Pastorelli L. Challenges in the Care of IBD Patients During the CoViD-19 Pandemic:Report From a "Red Zone" Area in Northern Italy. Inflamm. Bowel Dis. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314792

8. Zhang H, Li HB, Lyu JR et al. Specific ACE2 Expression in Small Intestinal Enterocytes may CauseGastrointestinal Symptoms and Injury after 2019-nCoV Infection. Int J Infect Dis 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311451

9. Hara T, Yamamoto C, Sawada R et al. Infection risk in a gastroenterological ward during a nosocomialCOVID-19 infection event. J Med Virol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320062

10. Karimi-Sari H, Rezaee-Zavareh MS. COVID-19 and viral hepatitis elimination programs: Are westepping backward? Liver Int 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319207

11. Hajifathalian K, Mahadev S, Schwartz RE et al. SARS-COV-2 infection (coronavirus disease 2019) forthe gastrointestinal consultant. World J. Gastroenterol. 2020; 26:1546-1553.http://www.ncbi.nlm.nih.gov/pubmed/?term=32327904

12. Zhen L, Lin T, Zhao ML et al. [Management strategy for the resumption of regular diagnosis andtreatment in gastrointestinal surgery department during the outbreak of coronavirus disease 2019(COVID-19)]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:321-326.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306596

13. Zhu L, Cai MY, Shi Q et al. [Analysis of selective endoscopy results during the epidemic ofcoronavirus disease 2019 (COVID-19)]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:327-331.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306597

Guidelines -Consensus1. Zochios V, Brodie D, Charlesworth M, Parhar KK. Delivering extracorporeal membrane oxygenation for

patients with COVID-19: what, who, when and how? Anaesthesia 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319081

2. Kranke P, Weibel S, Sitter M et al. Obstetric Anesthesia during the SARS-CoV-2 Pandemic - A BriefOverview of Published Recommendations for Action by National and International SpecialistSocieties and Committees. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 2020;55:266-274.

3. Ghelichkhani P, Esmaeili M. Prone Position in Management of COVID-19 Patients; a Commentary. ArchAcad Emerg Med 2020; 8:e48. http://www.ncbi.nlm.nih.gov/pubmed/?term=32309812

4. Mahmoudjafari Z, Alexander M, Roddy J et al. American Society for Transplantation and CellularTherapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Managementand Clinical Management for COVID-19 in Hematopoietic Cell Transplant and Cellular TherapyPatients in the United States. Biol Blood Marrow Transplant 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305359

5. Mahmoudjafari Z, Alexander M, Roddy J et al. American Society for Transplantation and CellularTherapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Managementand Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular TherapyPatients in the United States. Biol Blood Marrow Transplant 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305359


7. Mattei A, Amy de la Breteque B, Crestani S et al. Guidelines of clinical practice for the management ofswallowing disorders and recent dysphonia in the context of the COVID-19 pandemic. Eur. Ann.Otorhinolaryngol. Head Neck Dis. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32332004

8. Takhar A, Walker A, Tricklebank S et al. Recommendation of a practical guideline for safetracheostomy during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314050

9. David AP, Russell MD, El-Sayed IH, Russell MS. Tracheostomy guidelines developed at a largeacademic medical center during the COVID-19 pandemic. Head Neck 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329926

10. Sengupta S, Honavar SG, Sachdev MS et al. All India Ophthalmological Society - Indian Journal ofOphthalmology consensus statement on preferred practices during the COVID-19 pandemic. IndianJ Ophthalmol 2020; 68:711-724. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317433

11. Gallaher J, Charles A. Developing Guidelines for COVID-19 Management: A Moving Target. An invitedcommentary on "Evidence Based Management Guideline for the COVID-19 Pandemic - Reviewarticle". Int J Surg 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330655

12. Zic JA, Ai W, Akilov OE et al. (United States Cutaneous Lymphoma Consortium) Recommendationsfor Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic. J Am Acad Dermatol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305443

13. Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-Cov2 Interaction withRenin Angiotensin System. J Am Coll Cardiol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305401

14. Choi AD, Abbara S, Branch KR et al. Society of Cardiovascular Computed Tomography guidance foruse of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the AmericanCollege of Cardiology. J. Cardiovasc. Comput. Tomogr. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317235

15. Kasperkiewicz M, Schmidt E, Fairley JA et al. Expert recommendations for the management ofautoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333823

16. Mirza AK. Perspectives on vascular surgical practice change due to COVID-19 at a non-academictertiary care center. J. Vasc. Surg. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305385

17. Fulesdi B, Sarkany P, Szentkereszty Z, Gal J. [Challenges of anesthesiology and intensive care forCOVID-19 infection. Practical recommendation]. Orv. Hetil. 2020; 161:652-659.http://www.ncbi.nlm.nih.gov/pubmed/?term=32324357

18. Darwiche K, Ross B, Gesierich W et al. Recommendations for Performing Bronchoscopy in Times ofthe COVID-19 Pandemic. Pneumologie (Stuttgart, Germany) 2020.

19. Mitura K, Mysliwiec P, Rogula W et al. Guidelines for the management of surgical departments in non-uniform hospitals during the COVID-19 pandemic. Pol. Przegl. Chir. 2020; 92:48-59.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312919

20. Vivas D, Roldan V, Esteve-Pastor MA et al. [Recommendations on antithrombotic treatment during theCOVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of theSpanish Society of Cardiology]. Rev. Esp. Cardiol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327870

21. Heffernan DS, Evans HL, Huston JM et al. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2(SARS-CoV-2). Surg Infect (Larchmt) 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32310715

22. Jain VK, Vaishya R. COVID-19 and orthopaedic surgeons: the Indian scenario. Trop. Doct.2020:49475520921616. http://www.ncbi.nlm.nih.gov/pubmed/?term=32316857

23. Shen KL, Yang YH, Jiang RM et al. Updated diagnosis, treatment and prevention of COVID-19 inchildren: experts' consensus statement (condensed version of the second edition). World J Pediatr2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333248

Imaging1. Dane B, Brusca-Augello G, Kim D, Katz DS. Unexpected Findings of Coronavirus Disease (COVID-19)

at the Lung Bases on Abdominopelvic CT. AJR Am J Roentgenol 2020:1-4.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319792

2. Jie B, Liu X, Suo H et al. Clinical and Dynamic Computed Tomography Features of 24 Patients WithCoronavirus Disease 2019. Can Assoc Radiol J 2020:846537120918834.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306755

3. Jung EM, Stroszczynski C, Jung F. Contrast enhanced ultrasonography (CEUS) to detect abdominalmicrocirculatory disorders in severe cases of COVID-19 infection: First experience. Clin. Hemorheol.Microcirc. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333581

4. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms.Eur J Radiol 2020; 127:109009. http://www.ncbi.nlm.nih.gov/pubmed/?term=32325282

5. Chen RC, Tan TT, Chan LP. Adapting to a new normal? 5 key operational principles for a radiologyservice facing the COVID-19 pandemic. Eur Radiol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328761

6. Choi AD, Abbara S, Branch KR et al. Society of Cardiovascular Computed Tomography guidance foruse of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the AmericanCollege of Cardiology. J. Cardiovasc. Comput. Tomogr. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317235

7. Zhang FY, Qiao Y, Zhang H. CT imaging of the COVID-19. J Formos Med Assoc 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307320

8. Calvillo-Arguelles O, Abdel-Qadir H, Ky B et al. Modified Routine Cardiac Imaging Surveillance of AdultCancer Patients and Survivors during the COVID-19 Pandemic. JACC CardioOncol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309816

9. Fan N, Fan W, Li Z et al. Imaging characteristics of initial chest computed tomography and clinicalmanifestations of patients with COVID-19 pneumonia. Jpn J Radiol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318916

10. Xia T, Li J, Gao J, Xu X. Small Solitary Ground-Glass Nodule on CT as an Initial Manifestation ofCoronavirus Disease 2019 (COVID-19) Pneumonia. Korean J Radiol 2020; 21:545-549.http://www.ncbi.nlm.nih.gov/pubmed/?term=32323499

11. Lovas A, Hankovszky P, Korsos A et al. [Importance of imaging diagnostics in the care of COVID-19infected patients]. Orv. Hetil. 2020; 161:672-677. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324360

12. Shen Q, Wang M, Che R et al. Consensus recommendations for the care of children receivingchronic dialysis in association with the COVID-19 epidemic. Pediatr. Nephrol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333285

13. Moore S, Gardiner E. Point of care and intensive care lung ultrasound: A reference guide forpractitioners during COVID-19. Radiography (Lond) 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327383

14. Adair LB, 2nd, Ledermann EJ. Chest CT Findings of Early and Progressive Phase COVID-19 Infectionfrom a US Patient. Radiol Case Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313588

15. Li M. Chest CT features and their role in COVID-19. Radiol Infect Dis 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309528

16. Gao J, Liu JQ, Wen HJ et al. The unsynchronized changes of CT image and nucleic acid detection inCOVID-19: reports the two cases from Gansu, China. Respir Res 2020; 21:96.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321530

17. Lim ZY, Khoo HW, Hui TCH et al. Variable computed tomography appearances of COVID-19. SingaporeMed J 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312025

18. Abramowicz JS, Basseal JM. World Federation for Ultrasound in Medicine and Biology PositionStatement: How to Perform a Safe Ultrasound Examination and Clean Equipment in the Context ofCOVID-19. Ultrasound Med. Biol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327199

Immune response1. Chiappelli F, Khakshooy A, Greenberg G. CoViD-19 Immunopathology and Immunotherapy.

Bioinformation 2020; 16:219-222. http://www.ncbi.nlm.nih.gov/pubmed/?term=323082632. Giamarellos-Bourboulis EJ, Netea MG, Rovina N et al. Complex Immune Dysregulation in COVID-19

Patients with Severe Respiratory Failure. Cell Host Microbe 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320677

3. Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents 2020:105982. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305588

4. Zhu Z, Cai T, Fan L et al. Clinical value of immune-inflammatory parameters to assess the severity ofcoronavirus disease 2019. Int J Infect Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334118

5. Quinti I, Lougaris V, Milito C et al. A possible role for B cells in COVID-19?: Lesson from patients withAgammaglobulinemia. J Allergy Clin Immunol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333914

6. Xu B, Fan CY, Wang AL et al. Suppressed T cell-mediated immunity in patients with COVID-19: aclinical retrospective study in Wuhan, China. J Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315725

Management – misc. diseases1. Sanz-Santos J, Rami-Porta R, Call S. Lessons already learnt from the Covid-19 pandemic. J Thorac

Oncol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=323339792. Fudulu DP, Angelini GD. Cardiac surgery in the time of the coronavirus. J. Card. Surg. 2020.

http://www.ncbi.nlm.nih.gov/pubmed/?term=323334373. Donato MF, Invernizzi F, Lampertico P, Rossi G. HEALTH STATUS OF LIVER TRANSPLANTED

PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTEREXPERIENCE FROM MILAN. Clin Gastroenterol Hepatol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334081

4. Borchert A, Baumgarten L, Dalela D et al. Managing Urology Consultations during COVID-19Pandemic: Application of a Structured Care Pathway. Urology 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330531

5. Francis N, Dort J, Cho E et al. SAGES and EAES recommendations for minimally invasive surgeryduring COVID-19 pandemic. Surg. Endosc. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323016

6. Tang K, Gaoshan J, Ahonsi B. Sexual and reproductive health (SRH): a key issue in the emergencyresponse to the coronavirus disease (COVID- 19) outbreak. Reprod Health 2020; 17:59.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326943

7. Abramovitz I, Palmon A, Levy D et al. Dental care during the coronavirus disease 2019 (COVID-19)outbreak: operatory considerations and clinical aspects. Quintessence Int. 2020; 51:418-429.http://www.ncbi.nlm.nih.gov/pubmed/?term=32328595

8. Vegh T, Laszlo I, Juhasz M et al. [Practical Aspects of Anesthesia and Perioperative Care in COVID-19Infected Patients]. Orv. Hetil. 2020; 161:692-695. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324364

9. Day AT, Sher DJ, Lee RC et al. Head and neck oncology during the COVID-19 pandemic:Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.Oral Oncol 2020; 105:104684. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330858

10. Wennmann DO, Dlugos CP, Hofschroer A et al. [Handling of COVID-19 in the emergency department :Field report of the emergency ward of the University Hospital Munster]. Med Klin IntensivmedNotfmed 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322988

11. Glehen O, Kepenekian V, Bouche O et al. [Treatment of primary and metastatic peritoneal tumors inthe Covid-19 pandemic Proposals for prioritization from the RENAPE and BIG-RENAPE groups].2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328206

12. Richez C, Lazaro E, Lemoine M et al. Implications of COVID-19 for the management of patients withinflammatory rheumatic diseases. Joint Bone Spine 2020; 87:187-189.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321633

13. Williams AC, Hill LJ. The 4 D's of Pellagra and Progress. Int J Tryptophan Res 2020;13:1178646920910159. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327922

14. Yang L, Ren Y. Moral Obligation, Public Leadership, and Collective Action for Epidemic Preventionand Control: Evidence from the Corona Virus Disease 2019 (COVID-19) Emergency. Int J Environ ResPublic Health 2020; 17. http://www.ncbi.nlm.nih.gov/pubmed/?term=32326618

15. Moravvej Z, Soltani Moghadam R, Ahmadian Yazdi A, Shahraki K. COVID-19 Pandemic: OphthalmicPractice and Precautions in a Tertiary Eye Hospital in Iran. Infect Control Hosp Epidemiol 2020:1-6.

http://www.ncbi.nlm.nih.gov/pubmed/?term=3232161116. Patel RJ, Kejner A, McMullen C. Early Institutional Head and Neck Oncologic and Microvascular

Surgery Practice Patterns Across the United States During the SARS-CoV-2 (COVID19) Pandemic.Head Neck 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329923

17. Baddour K, Kudrick LD, Neopaney A et al. Potential Impact of the COVID-19 Pandemic on FinancialToxicity in Cancer Survivors. Head Neck 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329924

18. Bhattacharjee A, Patil VM, Dikshit R et al. Should we wait or not? The preferable option for patientswith stage IV oral cancer in COVID-19 pandemic. Head Neck 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329953

19. Korobelnik JF, Loewenstein A, Eldem B et al. Guidance for anti-VEGF intravitreal injections during theCOVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328757

20. Rassy E, Khoury-Abboud RM, Ibrahim N et al. What the oncologist needs to know about COVID-19infection in cancer patients. Future Oncol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323577

21. Kattan C, Badreddine H, Rassy E et al. The impact of the coronavirus pandemic on the managementof cancer patients in Lebanon: a single institutional experience. Future Oncol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32323581

22. Mattioli F, Fermi M, Ghirelli M et al. Tracheostomy in the COVID-19 pandemic. Eur Arch Otorhinolaryngol2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322959

23. Barbieri L, Talavera Urquijo E, Parise P et al. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19)emergency. Dis. Esophagus 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322892

24. Conforti C, Giuffrida R, Di Meo N, Zalaudek I. Management of advanced melanoma in the COVID-19era. Dermatol Ther 2020:eacronym. http://www.ncbi.nlm.nih.gov/pubmed/?term=32323399

25. Spiess PE, Greene J, Keenan RJ et al. Meeting the challenge of the 2019 novel coronavirus disease inpatients with cancer. Cancer 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324273

26. Sornsa-Ard T, Niramitsantiphong A, Liawrungrueang W. Management of Traumatic Spinal Fracture inthe Coronavirus Disease 2019 Situation. Asian Spine J 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32326671

27. Setzen M, Svider PF, Pollock K. COVID-19 and rhinology: A look at the future. Am. J. Otolaryngol.2020:102491. http://www.ncbi.nlm.nih.gov/pubmed/?term=32327218

28. Zhao N, Shi J, Zeng L, Yang S. [Clinical Characteristics and Coping Strategies of Neoplasms with2019 Novel Coronavirus Infection]. Zhongguo Fei Ai Za Zhi 2020; 23:261-266.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316713

29. Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: On the frontline of health serviceagainst COVID-19 in LMICs. Res Social Adm Pharm 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317154

30. Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designatedhospital during the COVID-19 epidemic. Res Social Adm Pharm 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32317153

31. Brough HA, Kalayci O, Sediva A et al. Managing childhood allergies and immunodeficiencies duringrespiratory virus epidemics - the 2020 COVID-19 pandemic. Pediatr. Allergy Immunol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319129

32. Szmuda T, Ali S, Sloniewski P, Group NW. Telemedicine in neurosurgery during the novel coronavirus(COVID-19) pandemic. Neurol. Neurochir. Pol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319670

33. MacIntyre CR, Heslop DJ. Public health, health systems and palliation planning for COVID-19 on anexponential timeline. Med. J. Aust. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319114

34. Silvestris N, Moschetta A, Paradiso A, Delvino A. COVID-19 Pandemic and the Crisis of HealthSystems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer CenterIstituto Tumori "Giovanni Paolo II" of Bari. Int J Environ Res Public Health 2020; 17.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316337

35. Patruno C, Fabbrocini G, Stingeni L, Napolitano M. The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319103

36. Cavicchiolo ME, Lolli E, Trevisanuto D, Baraldi E. Managing a tertiary-level NICU in the time of COVID-19: Lessons learned from a high-risk zone. Pediatr Pulmonol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315113

37. Werner MT, Carey RM, Albergotti WG et al. Impact of the COVID-19 Pandemic on the Management ofHead and Neck Malignancies. Otolaryngol Head Neck Surg 2020:194599820921413.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312163

38. Rameau A, Young VN, Amin MR, Sulica L. Flexible Laryngoscopy and COVID-19. Otolaryngol HeadNeck Surg 2020:194599820921395. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312166

39. Aminian A, Kermansaravi M, Azizi S et al. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. Obes. Surg. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314249

40. Thomas P, Baldwin C, Bissett B et al. Physiotherapy management for COVID-19 in the acute hospitalsetting: clinical practice recommendations. J. Physiother. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312646

41. Gnanasegaran G, Williams J, Huang HL, Bomanji JB. Coronavirus (COVID-19) Pandemic: What theNuclear Medicine Departments Should Know. J. Nucl. Med. Technol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312852

42. Pawar T, Pokharkar A, Gori J et al. The Technique and Justification for Minimally Invasive Surgery inCOVID-19 Pandemic: Laparoscopic Anterior Resection for Near Obstructed Rectal Carcinoma. J.Laparoendosc. Adv. Surg. Tech. A 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315244

43. Casale TB, Wang J, Nowak-Wegrzyn A. Acute At Home Management of Anaphylaxis During TheCovid-19 Pandemic. J Allergy Clin Immunol Pract 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315792

44. Perini GF, Fischer T, Gaiolla RD et al. How to manage lymphoid malignancies during novel 2019coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematol Transfus Cell Ther2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313873

45. Mathelin C, Nisand I. [Breast cancer management during the COVID 19 pandemic: the CNGOF takesaction]. Gynecol Obstet Fertil Senol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315805

46. Lim LW, Yip LW, Tay HW et al. Sustainable practice of ophthalmology during COVID-19: challengesand solutions. Graefes Arch Clin Exp Ophthalmol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314034

47. Marano L, Marrelli D, Roviello F. Cancer care under the outbreak of COVID-19: A perspective fromItalian tertiary referral center for surgical oncology. Eur. J. Surg. Oncol. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312591


49. Chevance A, Gourion D, Hoertel N et al. [Ensuring mental health care during the SARS-CoV-2epidemic in France: A narrative review]. Encephale 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312567

50. Wollina U. Challenges of Covid-19 Pandemic for Dermatology. Dermatol Ther 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314460

51. Amerio P, Prignano F, Giuliani F, Gualdi G. COVID-19 and psoriasis : should we fear for patients treatedwith biologics? Dermatol Ther 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314483

52. DeFilippis EM, Farr MA, Givertz MM. Challenges in Heart Transplantation in the Era of COVID-19.Circulation 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314596

53. Ma S, Yuan Z, Peng Y et al. Experience and suggestion of medical practices for burns during theoutbreak of COVID-19. Burns 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312568

54. Ellis R, Hay-David AGC, Brennan PA. Operating during the COVID-19 pandemic: How to reducemedical error. Br. J. Oral Maxillofac. Surg. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312584

55. Ahmed MZ, Ahmed O, Aibao Z et al. Epidemic of COVID-19 in China and associated PsychologicalProblems. Asian J Psychiatr 2020; 51:102092. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315963

56. Zhang J, Shuai L, Yu H et al. Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak. Asian JPsychiatr 2020; 51:102077. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315967

57. Diaz A, Sarac BA, Schoenbrunner AR et al. Elective surgery in the time of COVID-19. Am. J. Surg. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312477

58. Jean WC, Ironside NT, Sack KD et al. The impact of COVID-19 on neurosurgeons and the strategy fortriaging non-emergent operations: a global neurosurgery study. Acta Neurochir. (Wien.) 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314059

59. Heffernan DS, Evans HL, Huston JM et al. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2(SARS-CoV-2). Surg Infect (Larchmt) 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32310715

60. Fallon A, Dukelow T, Kennelly SP, O'Neill D. COVID-19 in Nursing Homes. QJM 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311049

61. Rajabally YA, Goedee HS, Attarian S, Hartung HP. Management challenges for chronic dysimmuneneuropathies during the COVID-19 pandemic. Muscle Nerve 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311114

62. Song JC, Wang G, Zhang W et al. Chinese expert consensus on diagnosis and treatment ofcoagulation dysfunction in COVID-19. Mil Med Res 2020; 7:19. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307014

63. Practitioners specialized in oral health and coronavirus disease 2019: Professional guidelines fromthe French society of stomatology, maxillofacial surgery and oral surgery, to form a common frontagainst the infectious risk. J Stomatol Oral Maxillofac Surg 2020; 121:155-158.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307085

64. Crossley J, Clark C, Brody F, Maxwell JH. Surgical Considerations for an Awake Tracheotomy Duringthe COVID-19 Pandemic. J. Laparoendosc. Adv. Surg. Tech. A 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311303

65. Nohuz E, Dubernard G, Lamblin G et al. [Gynecological surgery during the COVID-19 Pandemic: takehome messages]. Gynecol Obstet Fertil Senol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32311508

66. Campi R, Amparore D, Capitanio U et al. Assessing the Burden of Nondeferrable Major Uro-oncologicSurgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from ThreeItalian High-volume Referral Centres. Eur. Urol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307215

67. Tursen U, Tursen B, Lotti T. Coronavirus-Days in Dermatology. Dermatol Ther 2020:e13438.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307810

68. Kamate SK, Sharma S, Thakar S et al. Assessing Knowledge, Attitudes and Practices of dentalpractitioners regarding the COVID-19 pandemic: A multinational study. Dent Med Probl 2020; 57:11-17. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307930

69. Yang M, Dong H, Lu Z. Role of anaesthesiologists during the COVID-19 outbreak in China. Br JAnaesth 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307116

70. Samsami M, Zebarjadi Bagherpour J, Nematihonar B, Tahmasbi H. COVID-19 Pneumonia inAsymptomatic Trauma Patients; Report of 8 Cases. Arch Acad Emerg Med 2020; 8:e46.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309810

71. Michaud K, Wipfler K, Shaw Y et al. Experiences of Patients with Rheumatic Diseases in the USDuring Early Days of the COVID-19 Pandemic. ACR Open Rheumatol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311836

72. Arduino PG, Conrotto D, Broccoletti R. The outbreak of Novel Coronavirus disease (COVID-19) causeda worrying delay in the diagnosis of oral cancer in north-west Italy: the Turin Metropolitan Areaexperience. Oral Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306459

73. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19,SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020; 127:104362.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305883

74. Freeman EE, McMahon DE, Fitzgerald ME et al. The AAD COVID-19 Registry: CrowdsourcingDermatology in the Age of COVID-19. J Am Acad Dermatol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305438

75. Krajewska J, Krajewski W, Zub K, Zatonski T. COVID-19 in otolaryngologist practice: a review ofcurrent knowledge. Eur Arch Otorhinolaryngol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306118

76. Mugheddu C, Dell'Antonia M, Sanna S et al. Successful Guselkumab treatment in a psoriatic patientaffected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic.Dermatol Ther 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306513

77. Al Saleh AS, Sher T, Gertz MA. Multiple Myeloma in the Time of COVID-19. Acta Haematol. 2020:1-7.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305989

Management1. Nikhat S, Fazil M. Overview of Covid-19; its prevention and management in the light of Unani

medicine. Sci Total Environ 2020; 728:138859. http://www.ncbi.nlm.nih.gov/pubmed/?term=323341632. Gupta S, Federman DG. Hospital preparedness for COVID-19 pandemic: Experience from department

of medicine at Veterans Affairs Connecticut Healthcare System. Postgrad. Med. 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331509

3. Radovanovic D, Rizzi M, Pini S et al. Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure inPatients with COVID-19: A Management Strategy Proposal. J Clin Med 2020; 9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331217

4. Korsos A, Kupcsulik S, Lovas A et al. [Diagnostic steps and estimation of disease prognosis in COVID-19-infected patients]. Orv. Hetil. 2020; 161:667-671. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324359

5. Wennmann DO, Dlugos CP, Hofschroer A et al. [Handling of COVID-19 in the emergency department :Field report of the emergency ward of the University Hospital Munster]. Med Klin IntensivmedNotfmed 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322988

6. Patel B. Comment on "Dermatology Residents and the Care of COVID-19 Patients". J Am AcadDermatol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330631

7. Sharma KA, Kumari R, Kachhawa G et al. Management of the first patient with confirmed COVID-19 inpregnancy in India: From guidelines to frontlines. Int J Gynaecol Obstet 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32324897

8. Xu G, Yang Y, Du Y et al. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experienceto Evidence-Based Practice. Clin. Rev. Allergy Immunol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328954

9. Perricone C, Triggianese P, Bartoloni E et al. The anti-viral facet of anti-rheumatic drugs: Lessons fromCOVID-19. J Autoimmun 2020:102468. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317220

10. Choudhury R, Barrett CD, Moore HB et al. Salvage use of tissue plasminogen activator (tPA) in thesetting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markovdecision analysis. World J Emerg Surg 2020; 15:29. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312290

11. Poonia SK, Rajasekaran K. Information Overload: A Method to Share Updates among Frontline Staffduring the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820922988.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315261

12. Song Y, Wang W, Zhang L et al. Optimization of the intravenous infusion workflow in the isolationward for patients with coronavirus disease 2019. Int J Nurs Sci 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32313713

13. Yao W, Wang T, Jiang B et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan,China: lessons learnt and international expert recommendations. Br J Anaesth 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312571

14. Lyons C. Fibreoptic tracheal intubation in COVID-19: not so fast. Br J Anaesth 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312573

15. Singer BD, Jain M, Budinger GRS, Wunderink RG. A Call for Rational Intensive Care in the Era ofCOVID-19. Am. J. Respir. Cell Mol. Biol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315548

16. Sonis JD, Black L, Baugh J et al. Leveraging existing quality improvement communication strategiesduring the COVID-19 crisis: Creation of an Emergency Department COVID-19 Case Conference. AmJ Emerg Med 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312576

17. Ma K, Chen T, Han MF et al. [Clinical consideration and management of coronavirus disease 2019].Zhonghua Gan Zang Bing Za Zhi 2020; 28:222-228. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306656

18. Litton E, Bucci T, Chavan S et al. Surge capacity of intensive care units in case of acute increase indemand caused by COVID-19 in Australia. Med. J. Aust. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306408

19. Lee SH, Son H, Peck KR. Can post-exposure prophylaxis for COVID-19 be considered as one ofoutbreak response strategies in long-term care hospitals? Int J Antimicrob Agents 2020:105988.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305587

20. Baugh JJ, Sonis JD, Wittbold KA et al. Keeping pace: An ED communications strategy for COVID-19.Am J Emerg Med 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305156

Meta-analyses - systematic reviews1. Castagnoli R, Votto M, Licari A et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320004

2. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity ofdisease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.Diabetes Metab Syndr 2020; 14:395-403. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334395

3. Huang X, Wei F, Yang Z et al. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study. Prehosp. Disaster Med. 2020:1-9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326988

4. Loffredo L, Pacella F, Pacella E et al. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330304

5. Hu Y, Sun J, Dai Z et al. Prevalence and severity of corona virus disease 2019 (COVID-19): Asystematic review and meta-analysis. J Clin Virol 2020; 127:104371.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315817

6. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307322

7. Li JW, Han TW, Woodward M et al. The impact of 2019 novel coronavirus on heart injury: A systemicreview and Meta-analysis. Prog Cardiovasc Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305557

Mortality1. Wang L, Li J, Guo S et al. Real-time estimation and prediction of mortality caused by COVID-19 with

patient information based algorithm. Sci Total Environ 2020; 727:138394.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334207

2. Farkas CB, Petretei D, Babinszky G et al. [What to do about the deceased in suspected, probable andconfirmed COVID-19 cases]. Orv. Hetil. 2020; 161:713-722. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324985

3. Parikh A, Kumar AA, Jahangir E. Cardio-oncology Care in the Time of COVID-19 and the Role ofTelehealth. JACC CardioOncol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328590

4. Ferdinand KC, Nasser SA. African American COVID-19 Mortality: A Sentinel Event. J Am Coll Cardiol2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330545

5. Ge Y, Sun S. Estimation of Coronavirus Disease Case-Fatality Risk in Real Time. Emerg Infect Dis2020; 26. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315282

6. Shojaee S, Pourhoseingholi MA, Ashtari S et al. Predicting the mortality due to Covid-19 by the nextmonth for Italy, Iran and South Korea; a simulation study. Gastroenterol Hepatol Bed Bench 2020;13:177-179. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308940

On-line – IT – Apps1. Podpora M, Gardecki A, Beniak R et al. Human Interaction Smart Subsystem-Extending Speech-Based

Human-Robot Interaction Systems with an Implementation of External Smart Sensors. Sensors(Basel) 2020; 20. http://www.ncbi.nlm.nih.gov/pubmed/?term=32331291

2. Wang L, Li J, Guo S et al. Real-time estimation and prediction of mortality caused by COVID-19 withpatient information based algorithm. Sci Total Environ 2020; 727:138394.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334207

3. Wissel BD, Van Camp PJ, Kouril M et al. An Interactive Online Dashboard for Tracking COVID-19 inU.S. Counties, Cities, and States in Real Time. J Am Med Inform Assoc 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333753

556 Publications COVID-19 publications - Week 17 2020 · Update April 20 - April 26, 2020, dr....

Documents

Transcript of 556 Publications COVID-19 publications - Week 17 2020 · Update April 20 - April 26, 2020, dr....